Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cetrorelix - Tulane University

Next Previous
X
Search
Drug Profile

Cetrorelix - Tulane University

Alternative Names: Cetrorelix acetate; Cetrorelix pamoate; Cetrotide; NS 75A; NS 75B; SB 075; SB 75

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Tulane University
  • Developer AEterna Zentaris Inc; Merck Serono; Shionogi
  • Class Infertility therapies; Peptides
  • Mechanism of Action Gonadotropin releasing hormone inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Female infertility
  • Discontinued Benign prostatic hyperplasia; Breast cancer; Endometriosis; Ovarian cancer; Prostate cancer; Uterine leiomyoma

Most Recent Events

  • 16 Aug 2022 First Generic equivalent approved in USA for Female infertility
  • 01 Oct 2013 AEterna Zentaris completes transfer of worldwide manufacturing rights to cetrorelix to Merck KGaA (Merck Serono)
  • 01 Jul 2013 Handok Pharmaceuticals is now called Handok Inc

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top